TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32435960

Group type: EXPERIMENTAL
Intervention: Single-Incision Laparoscopic Colectomy (SILC)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Multi-Port Laparoscopic Colectomy (MPC)
Number of subjects: 200
Study: 36332661

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (loading dose 60 mg and two subsequent 30 mg doses at 2 and 5 hours after misoprostol administration)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo combined with usual-care nonsteroidal anti-inflammatory medications ± opioids
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Dextromethorphan
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study: 34404292

Group type: EXPERIMENTAL
Intervention: Smartphone use (SMA) - 30 minutes of social media apps before training sessions
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (CON) - 30 minutes of watching TV before training sessions
Number of subjects: 24
Study: 32142170

Group type: EXPERIMENTAL
Intervention: High atorvastatin
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: High rosuvastatin
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: High simvastatin
Number of subjects: 192

Group type: COMPARATOR
Intervention: Low atorvastatin
Number of subjects: 192

Group type: COMPARATOR
Intervention: Low rosuvastatin
Number of subjects: 192

Group type: COMPARATOR
Intervention: Low simvastatin
Number of subjects: 192
Study: 35627597

Group type: EXPERIMENTAL
Intervention: 25 mg/day of Tetraselmis chuii (TC)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 200 mg/day of Tetraselmis chuii (TC)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo group (200 mg/day of lactose powder)
Number of subjects: 46
Study: 34734030

Group type: EXPERIMENTAL
Intervention: Mechanical prophylaxis
Number of subjects: 410

Group type: COMPARATOR
Intervention: LMWH-combination-prophylaxis
Number of subjects: 410
Study: 32655024

Group type: EXPERIMENTAL
Intervention: 80 mg/d nano-curcumin
Number of subjects: 60
Study: 33205682

Group type: EXPERIMENTAL
Intervention: Siponimod
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35656203

Group type: EXPERIMENTAL
Intervention: 5 A's of Firearm Safety Counseling training
Number of subjects: 29

Group type: COMPARATOR
Intervention: Didactic education on firearm injury epidemiology and evidence‐based policies
Number of subjects: 29
Study: 33483443

Group type: EXPERIMENTAL
Intervention: YP Face IT (online psychotherapeutic intervention using social interaction skills training and cognitive-behavioural therapy)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: YP Face IT
Number of subjects: 224

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 224
Study: 33048904

Group type: EXPERIMENTAL
Intervention: Melatonin (10 mg)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 203
Study: 35736001

Group type: EXPERIMENTAL
Intervention: 2-mg trametinib containing 9% DMSO (test formulation)
Number of subjects: 65

Group type: COMPARATOR
Intervention: 2-mg trametinib containing 11% DMSO (reference formulation)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 65
Study: 34510203

Group type: EXPERIMENTAL
Intervention: Watermelon juice (WMJ) 500 mL daily for 2 weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Calorie-matched placebo (PLA)
Number of subjects: 17
Study: 36239565

Group type: EXPERIMENTAL
Intervention: White noise
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Brahms' lullaby
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control
Number of subjects: 59
Study: 33326122

Group type: EXPERIMENTAL
Intervention: Virtual reality rehabilitation system (30 minutes) + conventional occupational therapy (30 minutes)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional occupational therapy (60 minutes)
Number of subjects: 80
Study: 35817618

Group type: EXPERIMENTAL
Intervention: Lap‐Tap with liposomal bupivacaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: US‐Tap with liposomal bupivacaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Lap‐Tap and US‐Tap
Number of subjects: 100
Study: 33743788

Group type: EXPERIMENTAL
Intervention: AOT-EXO group (action observation treatment-based exoskeleton therapy)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: EXO group (exoskeleton therapy)
Number of subjects: 132

Group type: COMPARATOR
Intervention: CT group (conventional therapy)
Number of subjects: 132
Study: 32598244

Group type: EXPERIMENTAL
Intervention: MenACWY-TT (toddlers)
Number of subjects: 0

Group type: COMPARATOR
Intervention: MenC-CRM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MenACWY-TT (children)
Number of subjects: 0

Group type: COMPARATOR
Intervention: MenACWY-PS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MenACWY-TT booster
Number of subjects: 0
Study: 36251938

Group type: EXPERIMENTAL
Intervention: Controlled oxygenated rewarming (COR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Static cold storage (SCS)
Number of subjects: 0
Study: 33878017

Group type: EXPERIMENTAL
Intervention: Self-focused Augmented Reality (AR)
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Vicarious Reinforcement
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Self-focused AR and Vicarious Reinforcement
Number of subjects: 335

Group type: COMPARATOR
Intervention: Control
Number of subjects: 335
Study: 32692370

Group type: EXPERIMENTAL
Intervention: Clinical vignette of a white woman (20 participants, 43%)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Clinical vignette of an African American woman (20 participants, 43%)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Clinical vignette of a white man (3 participants, 7%)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Clinical vignette of an African American man (3 participants, 7%)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: All racial and gender groups
Number of subjects: 46

Group type: COMPARATOR
Intervention: Surveys
Number of subjects: 46
Study: 35314714

Group type: EXPERIMENTAL
Intervention: Risk prediction model for CKD
Number of subjects: 4601
Study: 32744859

Group type: EXPERIMENTAL
Intervention: Late luteal phase
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Higher health anxiety (HA) during late luteal phase
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Follicular phase
Number of subjects: 38
Study: 35854267

Group type: COMPARATOR
Intervention: Usual care SMS reminder
Number of subjects: 8391

Group type: COMPARATOR
Intervention: Behavioural plain text SMS reminder
Number of subjects: 8391

Group type: COMPARATOR
Intervention: Novel video sent as a link within the behavioural plain text SMS reminder
Number of subjects: 8391
Study: 33400856

Group type: EXPERIMENTAL
Intervention: Total sleep deprivation (DEP)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Normal sleep (CON)
Number of subjects: 13
Study: 34743575

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention delivered by trained lay volunteers (mentors)
Number of subjects: 104
Study: 34481460

Group type: EXPERIMENTAL
Intervention: Nasal High-Flow (NHF) cannula
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional Nasal Cannula (NC2)
Number of subjects: 36
Study: 33377700

Group type: EXPERIMENTAL
Intervention: Paclitaxel liposome, 135 mg/m2, administered via intravenous drip for a course of 3 weeks, with 10 mg dexamethasone in 100 ml normal saline on the first day and metoclopramide and panxi tora azole on the second day.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Paclitaxel liposome treatment for bone metastasis and pain.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Overall survival rate and median survival time after treatment.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Safety profile of the treatment.
Number of subjects: 40
Study: 35512482

Group type: EXPERIMENTAL
Intervention: Art-based intervention (TICK-B) during venipuncture
Number of subjects: 144

Group type: COMPARATOR
Intervention: No intervention (control group) during venipuncture
Number of subjects: 144
Study: 32969022

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) at a dose of 10 or 20 mg/kg/day for 14 weeks
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) in patients receiving clobazam
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD)
Number of subjects: 714

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 714
Study: 32201143

Group type: EXPERIMENTAL
Intervention: Condensed video ratings by nonexpert raters
Number of subjects: 13

Group type: COMPARATOR
Intervention: Expert ratings
Number of subjects: 13
Study: 32828644

Group type: EXPERIMENTAL
Intervention: Anger management psychoeducation programme (8 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 32
Study: 32145370

Group type: EXPERIMENTAL
Intervention: High-calorie food condition
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Low-calorie food condition
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Neutral/standard response inhibition
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Food stimuli blocks
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Food type
Number of subjects: 97
Study: 35102099

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program (60-minute sessions, 3 days per week for 16 weeks)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program
Number of subjects: 112
Study: 35476887

Group type: EXPERIMENTAL
Intervention: Buprenorphine buccal film (BBF) 300 mcg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Buprenorphine buccal film (BBF) 600 mcg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Buprenorphine buccal film (BBF) 900 mcg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immediate-release (IR) oxycodone 30 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immediate-release (IR) oxycodone 60 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33478837

Group type: EXPERIMENTAL
Intervention: Sutureless valves
Number of subjects: 910

Group type: COMPARATOR
Intervention: Conventional stented valves
Number of subjects: 910
Study: 34358471

Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg daily
Number of subjects: 185

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study: 32005475

Group type: EXPERIMENTAL
Intervention: Trained evaluators
Number of subjects: 10

Group type: COMPARATOR
Intervention: Untrained evaluators
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Faculty evaluators
Number of subjects: 10

Group type: COMPARATOR
Intervention: Residents
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All evaluators on CVM staging for all combined images
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 2D-digital lateral cephalograms with training
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 3D-CBCT images
Number of subjects: 10
Study: 36018356

Group type: EXPERIMENTAL
Intervention: Transradial access (TRA)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Transfemoral access (TFA)
Number of subjects: 130
Study: 34032923

Group type: EXPERIMENTAL
Intervention: Dexamethasone in addition to routine care
Number of subjects: 48

Group type: COMPARATOR
Intervention: Routine care only (Control)
Number of subjects: 48
Study: 32568368

Group type: EXPERIMENTAL
Intervention: Telephone and Short Message Service Support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 36216006

Group type: EXPERIMENTAL
Intervention: Allopurinol (up-titrated to 600 mg daily, 300 mg daily for moderate renal impairment)
Number of subjects: 5721

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 5721

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 5721
Study: 34607114

Group type: EXPERIMENTAL
Intervention: Selenised glucose (SeGlu) at 5 mg/kg
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Selenised glucose (SeGlu) at 10 mg/kg
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Selenised glucose (SeGlu)
Number of subjects: 360
Study: 35092498

Group type: EXPERIMENTAL
Intervention: Vonoprazan 10 mg administered every second day for 4 weeks
Number of subjects: 122

Group type: COMPARATOR
Intervention: Lansoprazole 15 mg administered every second day for 4 weeks
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Vonoprazan 10 mg administered every second day for the second 4 weeks
Number of subjects: 122

Group type: COMPARATOR
Intervention: Lansoprazole 15 mg administered every second day for the second 4 weeks
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Vonoprazan 10 mg administered every second day for the first 4 weeks
Number of subjects: 122

Group type: COMPARATOR
Intervention: Lansoprazole 15 mg administered every second day for the first 4 weeks
Number of subjects: 122
Study: 33751956

Group type: EXPERIMENTAL
Intervention: COBRA-BPS multicomponent hypertension management programme
Number of subjects: 2645
Study: 33818343

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy
Number of subjects: 259

Group type: COMPARATOR
Intervention: Control (waitlist, discussion group, or supportive therapy)
Number of subjects: 259

Group type: COMPARATOR
Intervention: PSWQ‐A
Number of subjects: 259
Study: 32853005

Group type: EXPERIMENTAL
Intervention: Clinician-Administered PTSD Scale (CAPS) with IRT estimation incorporating symptom weights and group-specific DIF
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Clinician-Administered PTSD Scale (CAPS) with symptom counts
Number of subjects: 506
Study: 36130667

Group type: EXPERIMENTAL
Intervention: Norgestrel 0.075 mg progestogen-only pill taken 6 hours late
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Norgestrel 0.075 mg progestogen-only pill missed completely
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Norgestrel 0.075 mg progestogen-only pill (both interventions)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Theoretical contraceptive protection
Number of subjects: 46
Study: 32401625

Group type: EXPERIMENTAL
Intervention: Education based on the BASNEF model including personal education and a manual CD of physical activity
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 40
Study: 35676163

Group type: EXPERIMENTAL
Intervention: Hybrid screw fixation (one fully threaded calcar screw & two partially threaded superior screws)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Partially threaded screws (all screws partially threaded)
Number of subjects: 20
Study: 34948661

Group type: EXPERIMENTAL
Intervention: Gender equality curriculum including script relationship training for two months
Number of subjects: 54

Group type: COMPARATOR
Intervention: Regular curriculum
Number of subjects: 54
Study: 32499257

Group type: EXPERIMENTAL
Intervention: Lower Socioeconomic Position (SEP)
Number of subjects: 1412
Study: 35091325

Group type: EXPERIMENTAL
Intervention: Abatacept treatment for 48 weeks
Number of subjects: 40
Study: 33105154

Group type: EXPERIMENTAL
Intervention: Mirror visual feedback + electromyographic biofeedback
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Mirror visual feedback
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46
Study: 32370540

Group type: EXPERIMENTAL
Intervention: High ammonia (HA) at 75 ± 5 ppm
Number of subjects: 176

Group type: COMPARATOR
Intervention: Low ammonia (LA) at 5 ± 5 ppm
Number of subjects: 176
Study: 34665672

Group type: EXPERIMENTAL
Intervention: 3-month vaginal ring
Number of subjects: 49

Group type: COMPARATOR
Intervention: 1-month vaginal ring
Number of subjects: 49
Study: 33757497

Group type: EXPERIMENTAL
Intervention: Genetic predisposition to type 2 diabetes
Number of subjects: 133010

Group type: EXPERIMENTAL
Intervention: Fasting glucose
Number of subjects: 133010

Group type: EXPERIMENTAL
Intervention: Glycemic traits
Number of subjects: 133010
Study: 32028895

Group type: EXPERIMENTAL
Intervention: Perceived link between HIV and TB
Number of subjects: 882

Group type: EXPERIMENTAL
Intervention: Link between HIV and TB
Number of subjects: 882

Group type: EXPERIMENTAL
Intervention: Stigmatization of both diseases by colleagues
Number of subjects: 882
Study: 34259202

Group type: EXPERIMENTAL
Intervention: Apalutamide
Number of subjects: 221

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 221
Study: 35781341

Group type: EXPERIMENTAL
Intervention: Ceftolozane/tazobactam
Number of subjects: 61

Group type: COMPARATOR
Intervention: Meropenem
Number of subjects: 61
Study: 32619868

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Sublingual buprenorphine-naloxone (BUP-NX)
Number of subjects: 73
Study: 35037328

Group type: EXPERIMENTAL
Intervention: Nomogram (developed using logistic and Lasso regression)
Number of subjects: 2113

Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 2113

Group type: COMPARATOR
Intervention: STOP-Bang
Number of subjects: 2113
Study: 33853794

Group type: COMPARATOR
Intervention: FOBT screening every other year
Number of subjects: 251528

Group type: COMPARATOR
Intervention: Once-only sigmoidoscopy screening
Number of subjects: 251528
Study: 32817078

Group type: EXPERIMENTAL
Intervention: LenMT at 25 mg/day
Number of subjects: 94

Group type: COMPARATOR
Intervention: LenMT at 5 mg/day
Number of subjects: 94
Study: 34449265

Group type: EXPERIMENTAL
Intervention: Active videogames (AVG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Running
Number of subjects: 0
Study: 35729041

Group type: EXPERIMENTAL
Intervention: Polypropylene (Prolene 6/0; Ethicon Inc.)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Polyglactin (Irradiated polyglactin 911, Vicryl Rapid™ 6/0; Ethicon Inc.)
Number of subjects: 31
Study: 34248660

Group type: EXPERIMENTAL
Intervention: Flywheel exercise at 0.025 kg m2
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Flywheel exercise at 0.05 kg m2
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Flywheel exercise at 0.075 kg m2
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Flywheel exercise at all loads
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Flywheel exercise at high load
Number of subjects: 30
Study: 34619239

Group type: EXPERIMENTAL
Intervention: Obese patients
Number of subjects: 1236

Group type: EXPERIMENTAL
Intervention: Underweight patients
Number of subjects: 1236

Group type: EXPERIMENTAL
Intervention: Overweight patients
Number of subjects: 1236

Group type: EXPERIMENTAL
Intervention: Normalweight men
Number of subjects: 1236

Group type: EXPERIMENTAL
Intervention: Obese patients receiving oxaliplatin added to standard CRT
Number of subjects: 1236
Study: 32640130

Group type: COMPARATOR
Intervention: Tofersen (20 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Tofersen (40 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Tofersen (60 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Tofersen (100 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 35721034

Group type: EXPERIMENTAL
Intervention: 2% grape seed extract mouthwash (GSE)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine mouthwash (CHX)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 45
Study: 35145761

Group type: EXPERIMENTAL
Intervention: Immediate Full Weight-Bearing (FWB)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Partial Weight-Bearing (PWB)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both FWB and PWB
Number of subjects: 32
Study: 34279428

Group type: EXPERIMENTAL
Intervention: Natural and Conventional Cosmetics
Number of subjects: 268
Study: 32673215

Group type: EXPERIMENTAL
Intervention: Sun Safe Partners Online
Number of subjects: 75

Group type: COMPARATOR
Intervention: Generic Online Sun Safety Information
Number of subjects: 75
Study: 35222688

Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation combined with modified VTD regimen (n = 25)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Improved VTD regimen (control group, n = 17)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation combined with modified VTD regimen
Number of subjects: 42

Group type: COMPARATOR
Intervention: Improved VTD regimen (control group)
Number of subjects: 42
Study: 35001953

Group type: EXPERIMENTAL
Intervention: Intraoperative mild hyperventilation (ETCO2 of 30-32 mmHg)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Conventional ventilation (ETCO2 of 35-40 mmHg)
Number of subjects: 104
Study: 33892777

Group type: EXPERIMENTAL
Intervention: 10 ?g lysergic acid diethylamide (LSD) orally every 3rd day for 6 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 32658765

Group type: EXPERIMENTAL
Intervention: Sham CED activation
Number of subjects: 25

Group type: COMPARATOR
Intervention: No sham activation
Number of subjects: 25
Study: 36220067

Group type: EXPERIMENTAL
Intervention: Single metreleptin injection
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Modified sham feeding (vagal stimulation)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 33739313

Group type: EXPERIMENTAL
Intervention: Traditional Acupuncture (TA)
Number of subjects: 1123

Group type: EXPERIMENTAL
Intervention: Electro-Acupuncture (EA)
Number of subjects: 1123

Group type: EXPERIMENTAL
Intervention: TA&EA (merged)
Number of subjects: 1123

Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 1123
Study: 32157250

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Number of subjects: 40
Study: 35098587

Group type: EXPERIMENTAL
Intervention: Glucose loading
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo loading
Number of subjects: 31
Study: 34281695

Group type: EXPERIMENTAL
Intervention: G-ALP (crossed screw fixation)
Number of subjects: 157

Group type: COMPARATOR
Intervention: G-TRI (parallel screw fixation)
Number of subjects: 157
Study: 36342143

Group type: EXPERIMENTAL
Intervention: Baxdrostat 2 mg
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Baxdrostat 1 mg
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Baxdrostat 0.5 mg
Number of subjects: 248

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248

Group type: COMPARATOR
Intervention: Baxdrostat 2 mg vs Placebo
Number of subjects: 248

Group type: COMPARATOR
Intervention: Baxdrostat 1 mg vs Placebo
Number of subjects: 248
Study: 34176575

Group type: EXPERIMENTAL
Intervention: Senior WISE memory intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Health promotion group
Number of subjects: 0